Vascular Dialysis Focus Sonavex’s EchoMark and EchoSure target vascular access and monitoring in vascular surgery, interventional radiology, and dialysis programs. With recent growth funding and NIH grants, there is capacity to scale sales and bring these solutions to hospitals managing high-volume cannulation and vessel surveillance.

AI Enabled Adoption EchoSure enables 3D ultrasound analysis of blood flow and vessel morphology without requiring ultrasound training, delivering a quick ROI for clinics with limited sonography capabilities. Ideal candidates include ICUs, EDs, nephrology labs, and other point-of-care settings.

Growth Funding Signals Recent funding milestones and NIH grants indicate strong growth and potential for co-development and co-marketing with hospital systems, creating entry points for pilot deployments and multi-department contracts.

Scale Portfolio A focused product family—EchoMark, EchoSure, and developing EchoMap and EchoGuide—supports scalable deployment through a lean team, with physician champions and KOLs already in place via advisory board.

Key Buyer Targets Primary buyers are vascular surgeons, interventional radiologists, nephrologists, and hospital procurement teams; craft a multi-department sales approach emphasizing outcomes improvement, cost reduction, shorter training, and flexible procurement to win pilots and scale across facilities.